Trichomonas vaginalis transcription-mediated amplification-based analyte-specific reagent and alternative target testing of primary clinical vaginal saline suspensions

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 1, 2010, Pages 66-72

  Munson, Erik ^a,b   Napierala, Maureen ^a   Basile, Janice ^a   Miller, Cheryl ^a   Burtch, Jason ^a   Hryciuk, Jeanne E ^a   Schell, Ronald F ^c,d  

^a Wheaton Franciscan Laboratory   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^c WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Analyte specific reagent; Confirmatory testing; Transcription mediated amplification; Trichomonas vaginalis; Vaginal saline suspensions; Wet mount

Indexed keywords

NUCLEIC ACID; REAGENT; SODIUM CHLORIDE;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HUMAN; LABORATORY DIAGNOSIS; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UTERINE ENDOCERVIX; VAGINA DISCHARGE;

EID: 77955836638     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.05.002     Document Type: Article

References (32)

1. Briselden A.M., Hillier S.H. Evaluation of affirm VP microbial identification test for Gardnerella vaginalis and Trichomonas vaginalis. J. Clin. Microbiol. 1994, 32:148-152.
2. Bruckner D.A. Urogenital specimens: direct saline mount. Clinical microbiology procedures handbook 2004, 9.6.6.1-9.6.6.4.. ASM Press, Washington, DC. H.D. Isenberg (Ed.).
3. Cates W., American Social Health Association Panel Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex. Transm. Dis. 1999, 26:S2-S7.
4. Centers for Disease Control and Prevention Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections-2002. Morb. Mortal. Wkly. Rep. 2002, 51(RR-15):1-37.
5. Centers for Disease Control and Prevention Sexually transmitted disease surveillance 2007 2008, U. S. Department of Health and Human Services, Atlanta, GA.
6. Chernesky M., Jang D., Luinstra K., Chong S., Smieja M., Cai W., Hayhoe B., Portillo E., MacRitchie C., Main C., Ewert R. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay. J. Clin. Microbiol. 2006, 44:400-405.
7. Comanor L., Anderson F., Ghany M., Perrillo R., Heathcote E.J., Sherlock C., Zitron I., Hendricks D., Gordon S.C. Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment. Am. J. Gastroenterol. 2001, 96:2968-2972.
8. Cotch M.F., Pastorek J.G.I.I., Nugent R.P., Hillier S.L., Gibbs R.S., Martin D.H., Eschenbach D.A., Edelman R., Carey J.C., Regan J.A., Krohn M.A., Klebanoff M.A., Rao A.V., Rhoads G.G. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis. 1997, 24:353-360. Vaginal Infections and Prematurity Study Group.
9. Dean R.B., Dixon W.J. Simplified statistics for small numbers of observations. Anal. Chem. 1951, 23:636-638.
10. Fouts A.C., Kraus S.J. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J. Infect. Dis. 1980, 141:137-143.
11. Garber G.E. The laboratory diagnosis of Trichomonas vaginalis. Can. J. Infect. Dis. Med. Microbiol. 2005, 16:35-38.
12. Gaydos C.A., Quinn T.C., Willis D., Weissfeld A., Hook E.W., Martin D.H., Ferrero D.V., Schachter J. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J. Clin. Microbiol. 2003, 41:304-309.
13. Gaydos C.A., Theodore M., Dalesio N., Wood B.J., Quinn T.C. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens. J. Clin. Microbiol. 2004, 42:3041-3045.
14. Hardick A., Hardick J., Wood B.J., Gaydos C. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples. J. Clin. Microbiol. 2006, 44:4197-4199.
15. Heine P., McGregor J.A. Trichomonas vaginalis: a reemerging pathogen. Clin. Obstet. Gynecol. 1993, 36:137-144.
16. Hobbs M.M., Kazembe P., Reed A.W., Miller W.C., Nkata E., Zimba D., Daly C.C., Chakraborty H., Cohen M.S., Hoffman I. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex. Transm. Dis. 1999, 26:381-387.
17. Huppert J.S., Mortensen J.E., Reed J.L., Kahn J.A., Rich K.D., Miller W.C., Hobbs M.M. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of T. vaginalis in young women. Clin. Infect. Dis. 2007, 45:194-198.
18. Kingston M.A., Bansal D., Carlin E.M. 'Shelf life' of Trichomonas vaginalis. Int. J. STD AIDS 2003, 14:28-29.
19. Laga M., Monoka A., Kivuvu M., Malele B., Tuliza M., Nzila N., Goeman J., Behets F., Batter V., Alary M. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993, 7:95-102.
20. Levett P.N., Brandt K., Olenius K., Brown C., Montgomery K., Horsman G.B. Evaluation of three automated nucleic acid amplification systems for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in first-void urine specimens. J. Clin. Microbiol. 2008, 46:2109-2111.
21. Lossick J.G. Epidemiology of urogenital trichomoniasis. Trichomonads parasitic in humans 1989, 311-323. Springer-Verlag, New York. B.M. Honigberg (Ed.).
22. Moncada J., Donegan E., Schachter J. Evaluation of CDC-recommended approaches for confirmatory testing of positive Neisseria gonorrhoeae nucleic acid amplification test results. J. Clin. Microbiol. 2008, 46:1614-1619.
23. Munson E., Boyd V., Czarnecka J., Griep J., Lund B., Schaal N., Hryciuk J.E. Evaluation of Gen-Probe APTIMA-based Neisseria gonorrhoeae and Chlamydia trachomatis confirmatory testing in a metropolitan setting of high disease prevalence. J. Clin. Microbiol. 2007, 45:2793-2797.
24. Munson E., Napierala M., Olson R., Endes T., Block T., Hryciuk J.E., Schell R.F. Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence. J. Clin. Microbiol. 2008, 46:3368-3374.
25. Munson E., Firmani M. Molecular diagnosis of Neisseria gonorrhoeae infection in the United States. Expert Opin. Med. Diagn. 2009, 3:327-343.
26. Nye M.B., Schwebke J.R., Body B.A. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am. J. Obstet. Gynecol. 2009, 200:188.e1-188.e7.
27. Riley D.E., Roberts M.C., Takayama T., Krieger J.N. Development of a polymerase chain reaction based diagnosis of Trichomonas vaginalis. J. Clin. Microbiol. 1992, 30:465-472.
28. Schachter J., Chow J.M., Howard H., Bolan G., Moncada J. Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised. J. Clin. Microbiol. 2006, 44:2512-2517.
29. Schwebke J.R., Hook E.W. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J. Infect. Dis. 2003, 188:465-468.
30. Triola M.F. Elementary statistics 1992, Addison Wesley, Boston. 5th ed.
31. Weinstock H., Berman S., Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspect. Sex. Reprod. Health 2004, 36:6-10.
32. Wiese W., Patel S.R., Patel S.C., Ohl C.A., Estrada C.A. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am. J. Med. 2000, 108:301-308.